New Drug ApprovalEC Approves Pharming’s Joenja for Activated PI3K Delta Syndrome EC Approves Pharming’s Joenja for Activated PI3K Delta Syndrome Read Post »
Drugs Safety AlertTakeda’s ADZYNMA Gets FDA Boxed Warning After Fatal Antibody Case Takeda’s ADZYNMA Gets FDA Boxed Warning After Fatal Antibody Case Read Post »
New Drug ApprovalGalderma Wins FDA Approval for OTC Differin Epiduo Acne Gel Galderma Wins FDA Approval for OTC Differin Epiduo Acne Gel Read Post »
New Drug ApprovalEC Grants EU‑Wide Approval for PYRUKYND in Thalassemia EC Grants EU‑Wide Approval for PYRUKYND in Thalassemia Read Post »
Clinical TrialsCHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children CHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children Read Post »
Clinical TrialsEli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Eli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Read Post »
New Drug ApprovalAstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... AstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... Read Post »
New Drug ApprovalGilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Gilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Read Post »
Clinical TrialsInnovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Innovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Read Post »
Clinical TrialsBoehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Boehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Read Post »
New Drug ApprovalBayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Bayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Read Post »
New Drug ApprovalHERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC HERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC Read Post »
Clinical TrialsBiogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Biogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Read Post »
Clinical TrialsSobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Sobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Read Post »
Clinical TrialsBicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Bicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Read Post »
Clinical TrialsReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD ReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD Read Post »
Clinical TrialsLilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Lilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Read Post »
Clinical TrialsInfex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Infex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Read Post »
Clinical TrialsBioMarin VOXZOGO Improves Growth and Reach in Children BioMarin VOXZOGO Improves Growth and Reach in Children Read Post »
Clinical TrialsPalvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Palvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Read Post »
Clinical TrialsSavara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Savara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Read Post »
Clinical TrialsRelay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Relay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Read Post »
Clinical TrialsRemepy Advanced Hybridopa After Positive Parkinson’s Trial Results Remepy Advanced Hybridopa After Positive Parkinson’s Trial Results Read Post »
Clinical TrialsShionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Shionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Read Post »
Clinical TrialsIpsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Ipsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Read Post »
Clinical TrialsANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses ANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses Read Post »
Clinical TrialsInnovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Innovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Read Post »
Clinical TrialsUCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown UCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown Read Post »
Clinical TrialsWave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Wave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Read Post »
Clinical TrialsAlterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Alterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Read Post »
Clinical TrialsBioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial BioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial Read Post »
Clinical TrialsSanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Sanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Read Post »
New Drug ApprovalJapan Expands GSK’s Arexvy Approval to At-Risk Adults Aged 18–49 Japan Expands GSK’s Arexvy Approval to At-Risk Adults Aged 18–49 Read Post »
Clinical TrialsMerck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Merck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Read Post »
New Drug ApprovalBoehringer Ingelheim Secures Japan Approval for JASCAYD in Pulmonary Fibros... Boehringer Ingelheim Secures Japan Approval for JASCAYD in Pulmonary Fibros... Read Post »
ResearchTeva Highlights the Unseen Psychological Toll of Tardive Dyskinesia Teva Highlights the Unseen Psychological Toll of Tardive Dyskinesia Read Post »
New Drug ApprovalFDA Approves AstraZeneca’s Baxfendy, an Aldosterone-Targeting Therapy... FDA Approves AstraZeneca’s Baxfendy, an Aldosterone-Targeting Therapy... Read Post »
Clinical TrialsRalinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Ralinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Read Post »
Clinical TrialsNovartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Novartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Read Post »
Clinical TrialsFDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure FDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure Read Post »
ResearchWhat Is Hantavirus? Understanding Its Spread, Structure, Symptoms, and Risk... What Is Hantavirus? Understanding Its Spread, Structure, Symptoms, and Risk... Read Post »
ResearchNIH-Funded Study Finds Testosterone May Suppress Glioblastoma Growth in Men NIH-Funded Study Finds Testosterone May Suppress Glioblastoma Growth in Men Read Post »
ResearchNIH-Funded Nature Study Finds Orforglipron Suppresses Pleasure-Driven Eatin... NIH-Funded Nature Study Finds Orforglipron Suppresses Pleasure-Driven Eatin... Read Post »
Clinical TrialsRegeneron Continues Melanoma Development After Phase 3 Trial Miss Regeneron Continues Melanoma Development After Phase 3 Trial Miss Read Post »
New Drug ApprovalFDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer FDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer Read Post »
New Drug ApprovalMHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa MHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa Read Post »
New Drug ApprovalFDA Approves Enhertu After Positive DESTINY-Breast Phase III Results FDA Approves Enhertu After Positive DESTINY-Breast Phase III Results Read Post »
Clinical TrialsXPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... XPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... Read Post »
Clinical TrialsPalvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Palvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Read Post »
Clinical TrialsAstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... AstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... Read Post »
